Your browser doesn't support javascript.
loading
ZMIZ2 promotes the development of triple-receptor negative breast cancer.
Zou, Xiaopan; Liu, Yan; Di, Jun; Wei, Wei; Watanabe, Nobumoto; Li, Jiang; Li, Xiaomeng.
Afiliação
  • Zou X; The Key Laboratory of Molecular Epigenetic, Institute of Genetics and Cytology, Northeast Normal University, No.5268 Renmin Street, Nanguan District, Changchun, 130024, Jilin, China.
  • Liu Y; Breast and Thyroid Surgery, Jilin Province People's Hospital, Changchun, 130021, Jilin, China.
  • Di J; The Key Laboratory of Molecular Epigenetic, Institute of Genetics and Cytology, Northeast Normal University, No.5268 Renmin Street, Nanguan District, Changchun, 130024, Jilin, China.
  • Wei W; Pathological Diagnostic Center, Jilin Province People's Hospital, Changchun, 130021, Jilin, China.
  • Watanabe N; The Key Laboratory of Molecular Epigenetic, Institute of Genetics and Cytology, Northeast Normal University, No.5268 Renmin Street, Nanguan District, Changchun, 130024, Jilin, China.
  • Li J; Bio-Active Compounds Discovery Research Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
  • Li X; Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, 510180, Guangdong, China. ljiang@gzhmu.edu.cn.
Cancer Cell Int ; 22(1): 52, 2022 Jan 31.
Article em En | MEDLINE | ID: mdl-35101047
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article